SCHEMBL5364276

SCHEMBL5364276

CCOC(=O)c1ccc(O)c(C(C)(C)C)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.68
CA1 P00915 5/20 0.68
CA2 P00918 5/20 0.68
CA7 P43166 5/20 0.68
CA9 Q16790 5/20 0.68
CA14 Q9ULX7 5/20 0.68
HSD17B2 P37059 1/20 0.60
HSP90AA1 P07900 4/20 0.59
HSP90AB1 P08238 4/20 0.59
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
ESRRA P11474 1/20 0.50
NR1H4 Q96RI1 1/20 0.50
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAOA P21397 1/20 0.49
RARA P10276 1/20 0.47
RARB P10826 1/20 0.47
RARG P13631 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23484283 0.86 CA12 (0.66) CA12CA1CA2CA7CA9
SCHEMBL12305564 0.85 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL7940256 0.84 HSP90AA1 (0.52) CA12CA1CA2CA7CA9
SCHEMBL18016984 0.83 ESR1 (0.59) HSP90AA1HSP90AB1ESR1LMNACYP1A2
SCHEMBL11404522 0.83 ESR1 (0.59) HSP90AA1HSP90AB1ESR1LMNACYP1A2
SCHEMBL19182178 0.83 ESR1 (0.59) HSP90AA1HSP90AB1ESR1LMNACYP1A2
SCHEMBL18016986 0.83 ESR1 (0.59) HSP90AA1HSP90AB1ESR1LMNACYP1A2
SCHEMBL19182177 0.83 ESR1 (0.59) HSP90AA1HSP90AB1ESR1LMNACYP1A2
SCHEMBL12305545 0.83 ALDH1A1 (0.54) CA12CA1CA2CA7CA9
SCHEMBL19317256 0.82 CA12 (0.56) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205409-B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBOTT LABORATORIES (US) 2007-04-17 US disclosed
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2005-06-16 US disclosed
WO-2005023762-A1 PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBOTT LABORATORIES (US) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 CA12 2859/4885CA1 2745/4885CA2 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.